
Oct 13, 2025 08:40 am UTC| Business Health
Pharmaceutical giants are pivoting toward direct-to-consumer sales and offering steep drug discounts in the United States after President Donald Trump called for lower prescription prices and reduced reliance on middlemen...

FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Oct 13, 2025 02:34 am UTC| Health Business Science
The U.S. Food and Drug Administration (FDA) has updated the safety labeling for Carvykti, the multiple myeloma therapy developed by Johnson Johnson and Legend Biotech, to include a warning about a rare but potentially...

U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Oct 10, 2025 01:41 am UTC| Health Business
The U.S. government has released its 2026 Medicare Advantage and prescription drug plan quality ratings, offering insight into how major health insurers performed in providing care to seniors. These annual ratings, issued...

Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Oct 01, 2025 02:57 am UTC| Technology Health Politics Science Governance
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to...

Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Sep 26, 2025 00:34 am UTC| Business Health Science
Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has approved its new therapy, Inluriyo, for the treatment of advanced or metastatic breast cancer in adult patients who have already undergone prior...

Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Sep 23, 2025 00:08 am UTC| Business Health
Innovent Biologics is gaining momentum in Chinas booming weight-loss drug market with its new therapy Xinermei, launched in July 2025. The once-weekly injectable, also known as mazdutide, joins Novo Nordisks Wegovy and Eli...